It is important for healthcare providers to be aware of these disparities and to work towards reducing diagnostic delays and improving care for all individuals with bleeding disorders and emphasize that women at parity of the disease severity suffer even further delays.
Join us to raise awareness in our 2023 campaign by sharing on LinkedIn using the app
Access our page with all resources dedicated to raise awareness on Women’s Health issues with content from 2022 (Webinars and new booklet) and new content on a weekly basis (webinars and podcasts) starting from today.
Rationale
Diagnostic delays in bleeding disorders can affect both women and men, but there is evidence to suggest that women and girls may experience longer delays in receiving a diagnosis. This may be due to several factors, including differences in presentation of symptoms, misperceptions of what is considered normal, and gender bias in healthcare.
Studies have shown that women and girls with bleeding disorders, such as von Willebrand disease (VWD), are more likely to be misdiagnosed with heavy menstrual bleeding (HMB) and to receive a delayed diagnosis compared to men and boys with VWD. This is because HMB is often considered a normal part of menstruation, and the symptoms may not be taken seriously. Women with bleeding disorders may also face stigma and shame related to their symptoms, which can further delay diagnosis.
Data From around the world:
France1: Median age at diagnosis was higher in Females with Hemophilia compared to men with Hemophilia:
- - 1y in Women vs 0.4y in Men (N = 12 vs 12, P = 0.09) in Severe Hemophilia
- - 5y in Women vs 1.3y in Men (N = 12 vs 12, P = 0.05) in Moderate Hemophilia
- - 0y in Women vs 9.7y in Men (N = 369 vs 377, P = 0.02) in Mild Hemophilia
Matched 409 Men and Women based on Hemophilia type and severity, lowest recorded FVIII:C/FIX:C level (±2%) and year of birth (±3 y)
Netherlands2: Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders
While age of first bleeding was similar (men 8.9 ± 13.6 (mean ±sd) years and women 10.6 ± 11.3 years (p = 0.075)) and the reason for referral for investigation was more frequently because of bleeding symptoms in women than in men (47.9% vs 36.6%, p= 0.002).
Diagnostic delays were different (time from first bleeding to diagnosis), mean years:
- - Men 7.7y ± 16.6
- - Women 11.6y ± 16.4
1092 patients with autosomal inherited bleeding disorders (834 von Willebrand disease (VWD), 196 rare bleeding disorders (RBDs) and 62 congenital platelet defects (CPDs)) of whom 665 (60.9%) were women.
USA3: A national multi-centre study of US haemophilia treatment centres study published in Haemophilia in 22 girls with hemophilia A or hemophilia B.
Diagnostic delays:
- - severe hemophilia in girls was delayed by a median of 6.5 months compared to boys
- - moderate hemophilia in girls was delayed by a median of 39 months compared to boys
- Molinari AC, Ambaglio C. Abstracts of the World Federation of Hemophilia, Virtual Summit - Connecting the Global Bleeding Disorders Community, June 2020. Haemophilia. 2020;26:3-140. doi:10.1111/hae.13941
- Atiq F, Saes JL, Punt MC, et al. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 2021;32:100726. doi:10.1016/j.eclinm.2021.100726
- Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia. 2014;20(2):136-143. doi:10.1111/hae.12364